Open to: students from around the world
Award: first place – USD 5,000; second place – USD 3,000; third place – USD 2,000
Description
The GSK | Kellogg | USAID Global Health Case Competition brings together business students from around the world to discuss global health challenges. Students will be placed into teams and, together, develop a proposed solution to a given global health case study that they will then present to a panel of judges. Students will also participate in site visits to local partners from both the public and private sectors (e.g., McKinsey & Company, the Bill & Melinda Gates Foundation, social enterprises, etc.).
GOALS:
- Build business-minded global health capacity in Africa, Asia, Europe, and the United States;
- Generate new thinking and solutions to real-world global health challenges;
- Identify (business/private sector) talent in the global health space;
- Raise awareness and interest in global health opportunities and challenges among the business community;
- Build relationships between students and schools across Africa, Asia, Europe, and the United States;
- Generate new global health case studies to be used in business school curriculum globally.
Eligibility
- 20 students for the year’s case competition will be accepted;
- Five teams of four students each will be comprised of students mixed across universities.
- Although there will be a focus on MBA program students, students in other related programs are eligible to apply.
- There is no prep work required of the teams – Kellogg faculty and staff will pre-assign each student to a team, and students will be notified of their assignments at the competition.
Benefits
- There will be 3 awards: first place – USD 5,000; second place -USD 3,000; third place – USD 2,000;
- All students accepted to the competition will be fully funded;
- GSK will generously provide expenses to fund travel to and from the event, and lodging/food expenses in London.
How to Apply?
Fill and submit your application form.
For more information please visit the official website.
No comments:
Post a Comment